Fierlbeck G - Search Results

1

Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors.

Bruchelt G, Handgretinger R, Fierlbeck G, Kimmig A, Dopfer R, Reisfeld RA, Treuner J, Niethammer D. Bruchelt G, et al. Among authors: fierlbeck g. Immunol Lett. 1989 Sep;22(3):217-20. doi: 10.1016/0165-2478(89)90194-6. Immunol Lett. 1989. PMID: 2509332

2

Chemotactic activity of substances derived from antibody-loaded tumor cells on granulocytes.

Schaber B, Bruchelt G, Meyle J, Jeschke B, Handgretinger R, Niethammer D, Mayer P, Rassner G, Fierlbeck G. Schaber B, et al. Among authors: fierlbeck g. Immunol Lett. 1994 Jun;41(1):67-71. doi: 10.1016/0165-2478(94)90058-2. Immunol Lett. 1994. PMID: 7959905

3

Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.

Bruchelt G, Fierlbeck G, Schiebel U, Bogenschütz O, Rassner G, Niethammer D. Bruchelt G, et al. Among authors: fierlbeck g. Eur J Clin Chem Clin Biochem. 1992 Sep;30(9):521-8. doi: 10.1515/cclm.1992.30.9.521. Eur J Clin Chem Clin Biochem. 1992. PMID: 1457613

4

Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2a.

Mayer P, Handgretinger R, Bruchelt G, Schaber B, Rassner G, Fierlbeck G. Mayer P, et al. Among authors: fierlbeck g. Melanoma Res. 1994 Apr;4(2):101-6. doi: 10.1097/00008390-199404000-00004. Melanoma Res. 1994. PMID: 8069095

5

Superantigen-induced lysis of melanoma cells.

Krull F, Holzer U, Ihle J, Bethge W, Fierlbeck G, Kalland T, Dohlsten M, Niethammer D, Dannecker GE. Krull F, et al. Among authors: fierlbeck g. Melanoma Res. 1997 Jun;7(3):214-22. doi: 10.1097/00008390-199706000-00005. Melanoma Res. 1997. PMID: 9195560

6

Expression of GD3 disialoganglioside antigen on peripheral T-lymphocytes in patients with disseminated malignant melanoma.

Welte B, Handgretinger R, Rassner G, Fierlbeck G. Welte B, et al. Among authors: fierlbeck g. Exp Dermatol. 1997 Apr;6(2):64-9. doi: 10.1111/j.1600-0625.1997.tb00148.x. Exp Dermatol. 1997. PMID: 9209886

7

Detection of circulating melanoma cells by immunomagnetic cell sorting.

Benez A, Geiselhart A, Handgretinger R, Schiebel U, Fierlbeck G. Benez A, et al. Among authors: fierlbeck g. J Clin Lab Anal. 1999;13(5):229-33. doi: 10.1002/(SICI)1098-2825(1999)13:5<229::AID-JCLA7>3.0.CO;2-Y. J Clin Lab Anal. 1999. PMID: 10494132 Free PMC article.

8

Neutralizing interferon beta antibodies in melanoma patients treated with recombinant and natural interferon beta.

Fierlbeck G, Schreiner T, Schaber B, Walser A, Rassner G. Fierlbeck G, et al. Cancer Immunol Immunother. 1994 Oct;39(4):263-8. doi: 10.1007/BF01525990. Cancer Immunol Immunother. 1994. PMID: 7954528 Free PMC article. Clinical Trial.

9

Treatment of psoriasis and psoriatic arthritis with interferon gamma.

Fierlbeck G, Rassner G. Fierlbeck G, et al. J Invest Dermatol. 1990 Dec;95(6 Suppl):138S-141S. doi: 10.1111/1523-1747.ep12875040. J Invest Dermatol. 1990. PMID: 2124243 Free article. Clinical Trial.

10

Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma.

Kötter I, Dürk H, Eckstein A, Zierhut M, Fierlbeck G, Saal JG. Kötter I, et al. Among authors: fierlbeck g. Clin Exp Rheumatol. 1996 May-Jun;14(3):313-5. Clin Exp Rheumatol. 1996. PMID: 8809448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters